Occurrence of toxigenic fungi in herbal drugs
Autor(a) principal: | |
---|---|
Data de Publicação: | 2006 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Microbiology |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822006000100009 |
Resumo: | The increase in the consumption of natural drugs have made their use a Public Health problem due to the possibility of access to products without adequate conditions of use. The concern with the quality of the natural products is due to the potential fungal contamination and the risk of the presence of mycotoxins. Ninety-one samples of medicinal plants were evaluated for the fungal contamination and the mycotoxigenic potential of Aspergillus and Penicillium isolated from the samples. Results indicated that predominant mycoflora was distributed in 10 genera. From these, 89.9% of the isolates corresponded to genera Aspergillus and Penicillium, which are extremely important from the mycotoxicological standpoint. 21.97% of the Aspergillus and Penicillium isolates proved to have the ability for producing aflatoxins (42.9%), ochratoxin A (22.4%) and citrinine (34.7%). The presence of toxigenic moulds represents a potential risk of mycotoxin contamination and considering the worldwide increased use of herbal products as alternative medicines, it is necessary setting standards for toxigenic moulds in crude herbal drugs in order to reduce the risks for consumers' health. |
id |
SBM-1_a2bbd8f73783289ff15fb1bdd2c079ab |
---|---|
oai_identifier_str |
oai:scielo:S1517-83822006000100009 |
network_acronym_str |
SBM-1 |
network_name_str |
Brazilian Journal of Microbiology |
repository_id_str |
|
spelling |
Occurrence of toxigenic fungi in herbal drugsherbal drugsmedicinal plantstoxigenic mouldsmycotoxinsThe increase in the consumption of natural drugs have made their use a Public Health problem due to the possibility of access to products without adequate conditions of use. The concern with the quality of the natural products is due to the potential fungal contamination and the risk of the presence of mycotoxins. Ninety-one samples of medicinal plants were evaluated for the fungal contamination and the mycotoxigenic potential of Aspergillus and Penicillium isolated from the samples. Results indicated that predominant mycoflora was distributed in 10 genera. From these, 89.9% of the isolates corresponded to genera Aspergillus and Penicillium, which are extremely important from the mycotoxicological standpoint. 21.97% of the Aspergillus and Penicillium isolates proved to have the ability for producing aflatoxins (42.9%), ochratoxin A (22.4%) and citrinine (34.7%). The presence of toxigenic moulds represents a potential risk of mycotoxin contamination and considering the worldwide increased use of herbal products as alternative medicines, it is necessary setting standards for toxigenic moulds in crude herbal drugs in order to reduce the risks for consumers' health.Sociedade Brasileira de Microbiologia2006-03-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822006000100009Brazilian Journal of Microbiology v.37 n.1 2006reponame:Brazilian Journal of Microbiologyinstname:Sociedade Brasileira de Microbiologia (SBM)instacron:SBM10.1590/S1517-83822006000100009info:eu-repo/semantics/openAccessBugno,AdrianaAlmodovar,Adriana Aparecida BuzzoPereira,Tatiana CaldasPinto,Terezinha de Jesus AndreoliSabino,Myrnaeng2006-05-19T00:00:00Zoai:scielo:S1517-83822006000100009Revistahttps://www.scielo.br/j/bjm/ONGhttps://old.scielo.br/oai/scielo-oai.phpbjm@sbmicrobiologia.org.br||mbmartin@usp.br1678-44051517-8382opendoar:2006-05-19T00:00Brazilian Journal of Microbiology - Sociedade Brasileira de Microbiologia (SBM)false |
dc.title.none.fl_str_mv |
Occurrence of toxigenic fungi in herbal drugs |
title |
Occurrence of toxigenic fungi in herbal drugs |
spellingShingle |
Occurrence of toxigenic fungi in herbal drugs Bugno,Adriana herbal drugs medicinal plants toxigenic moulds mycotoxins |
title_short |
Occurrence of toxigenic fungi in herbal drugs |
title_full |
Occurrence of toxigenic fungi in herbal drugs |
title_fullStr |
Occurrence of toxigenic fungi in herbal drugs |
title_full_unstemmed |
Occurrence of toxigenic fungi in herbal drugs |
title_sort |
Occurrence of toxigenic fungi in herbal drugs |
author |
Bugno,Adriana |
author_facet |
Bugno,Adriana Almodovar,Adriana Aparecida Buzzo Pereira,Tatiana Caldas Pinto,Terezinha de Jesus Andreoli Sabino,Myrna |
author_role |
author |
author2 |
Almodovar,Adriana Aparecida Buzzo Pereira,Tatiana Caldas Pinto,Terezinha de Jesus Andreoli Sabino,Myrna |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Bugno,Adriana Almodovar,Adriana Aparecida Buzzo Pereira,Tatiana Caldas Pinto,Terezinha de Jesus Andreoli Sabino,Myrna |
dc.subject.por.fl_str_mv |
herbal drugs medicinal plants toxigenic moulds mycotoxins |
topic |
herbal drugs medicinal plants toxigenic moulds mycotoxins |
description |
The increase in the consumption of natural drugs have made their use a Public Health problem due to the possibility of access to products without adequate conditions of use. The concern with the quality of the natural products is due to the potential fungal contamination and the risk of the presence of mycotoxins. Ninety-one samples of medicinal plants were evaluated for the fungal contamination and the mycotoxigenic potential of Aspergillus and Penicillium isolated from the samples. Results indicated that predominant mycoflora was distributed in 10 genera. From these, 89.9% of the isolates corresponded to genera Aspergillus and Penicillium, which are extremely important from the mycotoxicological standpoint. 21.97% of the Aspergillus and Penicillium isolates proved to have the ability for producing aflatoxins (42.9%), ochratoxin A (22.4%) and citrinine (34.7%). The presence of toxigenic moulds represents a potential risk of mycotoxin contamination and considering the worldwide increased use of herbal products as alternative medicines, it is necessary setting standards for toxigenic moulds in crude herbal drugs in order to reduce the risks for consumers' health. |
publishDate |
2006 |
dc.date.none.fl_str_mv |
2006-03-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822006000100009 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822006000100009 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/S1517-83822006000100009 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Microbiologia |
publisher.none.fl_str_mv |
Sociedade Brasileira de Microbiologia |
dc.source.none.fl_str_mv |
Brazilian Journal of Microbiology v.37 n.1 2006 reponame:Brazilian Journal of Microbiology instname:Sociedade Brasileira de Microbiologia (SBM) instacron:SBM |
instname_str |
Sociedade Brasileira de Microbiologia (SBM) |
instacron_str |
SBM |
institution |
SBM |
reponame_str |
Brazilian Journal of Microbiology |
collection |
Brazilian Journal of Microbiology |
repository.name.fl_str_mv |
Brazilian Journal of Microbiology - Sociedade Brasileira de Microbiologia (SBM) |
repository.mail.fl_str_mv |
bjm@sbmicrobiologia.org.br||mbmartin@usp.br |
_version_ |
1752122200541888512 |